The lipid lowering efficacy of PCSK9 inhibitors alone vs. statins alone: a meta-analysis

By afschroeder • March 5, 2026

Kyan K, Gornbein J, Saver J. The lipid lowering efficacy of PCSK9 inhibitors alone vs. statins alone: a meta-analysis. Front Cardiovasc Med. 2026 Feb 17;13:1769430. doi: 10.3389/fcvm.2026.1769430. PMID: 41783026; PMCID: PMC12954586.

Tags: Atherosclerosis, DOM STAT, General Internal Medicine, hyperlipidemia, LDL cholesterol, lipid lowering agent, PCSK9 inhibitors, Publications, Statins

Pilot demonstration for physician compensation incentives to improve diagnostic specificity in clinical documentation

Burstein DS, Schwartz N, Ganguly A, Hanak MA, Zimmermann LJ, Keshavarzian A. Pilot demonstration for physician compensation incentives to improve diagnostic specificity in clinical documentation.[...]

A meta-analysis of smoking and fracture risk to update the FRAX® tool

Schini M, Johansson H, Harvey NC, Lorentzon M, Liu E, Vandenput L, Leslie WD, Åkesson KE, Anderson FA, Azagra-Ledesma R, Bager CL, Beaudart C, Bischoff-Ferrari[...]

“And-Not But”: Experiencing Dementia Through Poetry

Tsevat RK, Campo R. "And-Not But": Experiencing Dementia Through Poetry. JAMA. 2026 Mar 4. doi: 10.1001/jama.2026.0168. Epub ahead of print. PMID: 41779412.